#PharmaNews #PharmaResults #EarningsUpdate #IndianPharma #PharmaUpdates #Harshal #PharmawithHJ #HJ Gland Pharma FY25 Results: Strong Margins, 31 Product Launches Gland Pharma Limited FY25 Results: Margins Hold Strong, Strategy Gathers Steam Financial Highlights: - FY25 Revenue: 5,617 Cr (1% YoY) - EBITDA Margin: 1,269 Cr (5% YoY) | Margin 23% - PAT: 698 Cr (10% YoY) | Margin at 12% - Dividend: 18/share final dividend recommended Business Highlights: - 31 product launches in FY25, including new molecules like Latanoprost & Dexamethasone - 32 ANDA approvals, 24 filings U.S
The cosmetic impact can be distressing and undermine adherence
What is Lexapro and how does it work
Bain, S.L
A writer who crafts content and articles from a unique A new wave of skin and hair treatments is reshaping beauty, and this time, the revolution is happening beneath the surface
Focus on: Small, frequent meals rather than three large meals Nutrient-dense foods to ensure adequate vitamin and mineral intake Adequate protein to preserve muscle mass during weight loss Complex carbohydrates to maintain stable blood glucose levels Managing orthostatic hypotension involves rising slowly from sitting or lying positions, allowing your cardiovascular system time to adjust
